Adaptimmune Therapeutics (NASDAQ:ADAP – Get Free Report) had its price objective cut by stock analysts at Scotiabank from $3.15 to $1.40 in a report issued on Friday,Benzinga reports. The brokerage ...
Our latest restaurant news column offers details on a move for Cowboy Cantina; the reopening of Hotel Zozo's restaurant space ...
Israel’s military carried out multiple waves of deadly airstrikes across Lebanon targeting suspected Hezbollah sites, as ...
An attorney resigned from the law firm Skadden, Arps, Slate, Meagher & Flom resigned, posting a a sharply critical ...
Parliamentary committee urges additional funds for fertilizer sector, expansion of nano urea and DAP production, and ...
DAP has reaffirmed its unity and strategic focus following the party election as it gears up to secure victory in the 16th ...
The Star on MSN22h
PS Ronoh: All NCPB stores to have fertiliser by MondayThe government has acknowledged a fertiliser shortage in the country as it assured farmers that deliveries will be made by next week.Agriculture Principal Secretary Paul Ronoh confirmed that most ...
Research analysts at StockNews.com initiated coverage on shares of Edap Tms (NASDAQ:EDAP – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback